Literature DB >> 591128

Human tumour--lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumour cells.

B M Vose, F Vánky, E Klein.   

Abstract

Lymphocytes prepared from the blood, tumour-draining lymph node and tumour were tested for immune reactivity with freshly isolated autologous tumour cells from biopsies. Reactivity was assessed by the autologous tumour stimulation assay and by lymphocytotoxicity. Activity was found in 6/11 blood preparations, 7/10 lymph nodes and 1/7 tumour-infiltrating lymphocytes in tumour stimulation assays and in 6/19 blood, 8/18 lymph-node and 5/20 tumour-infiltrating lymphocytes in cytotoxicity assays. Tests with material from patients with nasopharyngeal carcinoma showed a higher frequency of cytotoxicity in the tumour-infiltrating lymphocytes than in other solid tumours. There was a correlation between results of the two assays when performed on the same preparations and between the levels of reactivity in lymph node and blood from the same patient. Cytotoxicity in the lymph nodes showed specificity in that cells from a long-term culture (K562) known to be sensitive to natural killer activity and from allogeneic tumour biopsies were only rarely damaged. Cytotoxicity against K562 was more frequently determined in blood lymphocytes. Tumour-infiltrating lymphocytes were non-reactive in patients when the blood and lymph-node lymphocytes were active.

Entities:  

Mesh:

Year:  1977        PMID: 591128     DOI: 10.1002/ijc.2910200612

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  34 in total

1.  Comparison of recombinant-interleukin-2-activated peripheral blood and tumor-infiltrating lymphocytes of patients with epithelial ovarian carcinoma: cytotoxicity, growth kinetics and phenotype.

Authors:  E Lotzová; C A Savary; R S Freedman; C L Edwards; M Morris
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  Lysis by interleukin 2-stimulated tumor-infiltrating lymphocytes of autologous and allogeneic tumor target cells.

Authors:  M Radrizzani; C Gambacorti-Passerini; G Parmiani; G Fossati
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Autologous tumor killing and natural cytotoxic activity of tumor-associated macrophages in cancer patients.

Authors:  E Yanagawa; A Uchida; M Moore; M Micksche
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

Review 4.  The immunobiological effects of interleukin-2 in vivo.

Authors:  R A Janssen; N H Mulder; T H The; L de Leij
Journal:  Cancer Immunol Immunother       Date:  1994-10       Impact factor: 6.968

5.  Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas.

Authors:  T L Whiteside; S Miescher; J Hurlimann; L Moretta; V von Fliedner
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

Review 6.  Activation of lymphocyte anti-tumour responses in man: effector heterogeneity and the search for immunomodulators.

Authors:  B M Vose
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

7.  Natural killer activity of peripheral blood lymphocytes and its relation to histopathological factors of lung cancer.

Authors:  A Terazawa; N Tanaka; N Senou; F Inoue; H Matsuura; A Gouchi; S Fuchimoto; H Mimura; K Orita
Journal:  Jpn J Surg       Date:  1987-07

8.  Effects of orally administered retinol on natural killer cell activity in wild type BALB/c and congenitally athymic BALB/c mice.

Authors:  L D Fraker; S A Halter; J T Forbes
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

9.  Surface phenotypes of human peripheral blood mononuclear cells from patients with gastrointestinal carcinoma.

Authors:  G Boltz; E Penner; C Holzinger; S Bakos; A Fellinger; M Walgram; C Wiltschke; H Rumpold; K Langer; A Gangl
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

10.  Immunology of tumor infiltrating lymphocytes.

Authors:  E C Holmes
Journal:  Ann Surg       Date:  1985-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.